Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
151-165 of 249
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
NeuroFrontiersTremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
Jerome Lisk, MD, MBA, M.S., FAAN
Emile Maamary
Mark Elias
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiersBridging the Gap: New Consensus Recommendations for Adult DMD Care
Rosaline Quinlivan
Ryan Quigley
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiersTransitioning to Adult Care in DMD: Strategies for Long-Term Support
Rosaline Quinlivan
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiersSupporting Adults With DMD: A Guide to Acute and Long-Term Planning
Rosaline Quinlivan
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiersReducing the Burden of gMG with a Novel B-Cell Therapy
Richard Nowak, MD, MS
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiersInvestigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
Richard Nowak, MD, MS
- advertisement
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiersImproving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
Andrew J. Solomon, MD
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
On the Frontlines of CIDPAdvancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
Karissa Gable, MD, FAAN
Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
NeuroFrontiersHarnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention
Kelly Sloane, MD
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
On the Frontlines of Multiple SclerosisEnhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
Mark Gudesblatt, MD
Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
NeuroFrontiersInflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care
Prajwal Ciryam, MD, PhD
Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
NeuroFrontiersGut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
- advertisement
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
On the Frontlines of Multiple SclerosisManaging MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Charles Turck, PharmD, BCPS, BCCCP
Kimberly DiMauro, DO
Carol Swetlik, MD
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
On the Frontlines of Multiple SclerosisAging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Charles Turck, PharmD, BCPS, BCCCP
Yinan Zhang, MD
Sarah A. Morrow, MD, MS, FRCPC, FAAN
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
On the Frontlines of Multiple SclerosisMS Management: Strategies for Ensuring Equitable Access to Teleneurology
Marisa McGinley, DO
